Annual report pursuant to Section 13 and 15(d)

Income Tax Expense (Tables)

v2.4.1.9
Income Tax Expense (Tables)
12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Benefit (Provision)

The Company’s income tax benefit/(provision) is as follows:

 

    Years Ended December 31,  
    2014     2013  
Current   $ 1,295,979     $ 736,334  
Deferred     132,379     $ 203,664  
Change in Valuation Allowance     (1,428,358 )   $ (939,998 )
Income Tax Benefit   $ -     $ -  

Components of Deferred Tax Assets and Related Valuation Allowances

The principle components of the deferred tax assets and related valuation allowances as of December 31, 2014 and 2013 are as follows:

 

    Years Ended December 31,  
    2014     2013  
Reserves and other   $ 684,830     $ 844,729  
Net operating loss carry-forwards     18,754,066       17,165,809  
Valuation Allowance     (19,438,896 )     (18,010,538 )
Net   $ -     $ -  

Reconciliation of Income Taxes Using Statutory U.S. Income Tax Rate and Benefits from Income Taxes

The reconciliation of income taxes using the statutory U.S. income tax rate and the benefit from income taxes for the years ended December 31, 2014 and 2013 are as follows:

 

    Years Ended December 31,  
    2014     2013  
Statutory U.S. Federal Income Tax Rate     (35.0 %)     (35.0 %)
New Jersey State income taxes, net of U.S.                
Federal tax effect     (5.9 %)     (5.9 %)
Change in Valuation Allowance     40.9 %     40.9 %
Net     0.0 %     0.0 %